JOHNSON & JOHNSON is 265.5x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($574.10 B vs $2.16 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PAHC | JNJ |
|---|---|---|
| Market cap | $2.16 B | $574.10 B |
| US-listed rank | #2045 | #20 |
| Revenue (latest FY) | $1.30B | $94.19B |
| Net income (latest FY) | $48.26M | $26.80B |
| Net margin | 3.7% | 28.5% |
| P/E (trailing FY) | 44.8 | 21.4 |
| SEC filings | 733 | 984 |
JOHNSON & JOHNSON is 265.5x more valuable than PHIBRO ANIMAL HEALTH CORP by market capitalization ($574.10 B vs $2.16 B).
In their latest fiscal years, PHIBRO ANIMAL HEALTH CORP reported $1.30B in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: PHIBRO ANIMAL HEALTH CORP and JOHNSON & JOHNSON, or browse the full rankings.